Results
In-person events
Out-of-Office Live
Speaker:
Katie Murray, DO, MS, FACS
Ruth's Chris Steak House, 375 Revolution Dr, Somerville, MA 02145
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Chinedu Mmeje, MD, FACS
The Henry Phoenix, 4455 E. Camelback Rd, Phoenix, AZ 85018
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Patrick J. Hensley, MD
Tony's of Lexington, 401 W Main Street, Lexington, KY 40507
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Gautam Jayram, MD
The Capital Grille, 94 Perimeter Center W, Dunwoody, GA 30346
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Katie Murray, DO, MS, FACS
Artisan, 1 Memorial Road, West Hartford, CT 06107
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
In-Office Live
Speaker:
Chad Reichard, MD
Idaho Urologic Institute, 2855 E Magic View Dr., Meridian, ID 83642
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Gautam Jayram, MD
Bascom's Chop House, 665 Ulmerton Road, Clearwater, FL 33762
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Chinedu Mmeje, MD, FACS
Trulucks, 10225 Research Blvd, Austin, TX 78759
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Aaron Berger, MD
Baker Street Steakhouse, 4820 N Clinton Street, Fort Wayne, IN 46825
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Aaron Berger, MD
Ruth's Chris Steak House, 755 West Big Beaver Road, Troy, MI 48084
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Ravi Chauhan, MD
Ruth's Chris Steak House, 17840 Dallas Parkway, Dallas, TX 75287
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.
Out-of-Office Live
Speaker:
Lawrence Karsh, MD, FACS, CPI
Hilton Phoenix at the Peak, 7677 N 16th St., Phoenix, AZ 85020
Description:
Please join us for an interactive discussion on the role of ADSTILADRIN® in managing patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). During this discussion, we’ll introduce ADSTILADRIN and explain its mechanism of action, review clinical trial data showing the safety and efficacy of ADSTILADRIN, and finally, discuss practical considerations that may help facilitate the successful implementation of ADSTILADRIN into clinical practice.